Price $0.76 |
Market Cap
19.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
21.8
|
P/B
-
|
P/S
1.42
|
Dividend %
-
|
|
P/CF
43.1
|
P/FCF
-
|
Op. Cash Flow
1.1K
|
FCF
-
|
|
Op. Margin
10.60%
|
Net Margin
6.50%
|
ROE
-22.80%
|
ROI
-89.30%
|
|
ROA
19.90%
|
EPS Growth
135.20%
|
Current Ratio
0.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 9.8M | Strong Buy |
| Lannett Company, Inc. (LCI) | $20.85 | - | - | 763.2M | Strong Buy |
| Genesis Healthcare Inc (GEN) | $1.48 | - | - | 265.8M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $16.55 | - | - | 602.6M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.37 | - | - | 12.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
